Rafael Bejar is Sr VP & Chief Medical Officer of Aptose Biosciences Inc.. Currently has a direct ownership of 110,000 shares of APTO, which is worth approximately $28,600. The most recent transaction as insider was on Jan 19, 2023, when has been sold 100,000 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
0% 3M change
0% 12M change
Total Value Held $28,600

Rafael Bejar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2023
BUY
Grant, award, or other acquisition
-
100,000 Added 47.62%
110,000 Common Shares
Nov 19 2021
BUY
Open market or private purchase
$25,600 $2.56 p/Share
10,000 Added 50.0%
10,000 Common Shares
RB

Rafael Bejar

Sr VP & Chief Medical Officer
Toronto, A6

Track Institutional and Insider Activities on APTO

Follow Aptose Biosciences Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APTO shares.

Notify only if

Insider Trading

Get notified when an Aptose Biosciences Inc. insider buys or sells APTO shares.

Notify only if

News

Receive news related to Aptose Biosciences Inc.

Track Activities on APTO